Bioengineering a Human Dermal Equivalent Using Induced Pluripotent Stem Cell-Derived Fibroblasts to Support the...

Area of Science:

• Regenerative Medicine
• Tissue Engineering
• Stem Cell Biology

Background:

• In vitro tissue models are crucial for research but face challenges with cell supply consistency and health.
• Established cell lines can be cancerous, while primary cells exhibit batch-to-batch variability.
• Induced pluripotent stem cells (iPSCs) provide a consistent and adaptable cell source for tissue modeling.

Purpose of the Study:

• To develop a dermal equivalent using iPSC-derived fibroblasts as a consistent and reliable cell source.
• To create a full-thickness skin model that accurately mimics human skin structure and composition.
• To demonstrate the potential of iPSC-based models for future customized tissue engineering applications.

Main Methods:

• Utilized an induced pluripotent stem cell-derived fibroblast population to construct a dermal equivalent.
• Assessed the structural and compositional similarity of the iPSC-derived dermal model to primary fibroblast controls.
• Developed a full-thickness skin model by supporting an overlying epidermis on the dermal equivalent.

Main Results:

• The iPSC-derived dermal equivalent exhibited consistent tissue construct formation, mirroring primary fibroblast controls.
• The developed full-thickness skin model successfully supported an overlying epidermis.
• Key skin-related markers were expressed and correctly localized within the organized epidermis of the model.

Conclusions:

• iPSC-derived fibroblasts provide a consistent and viable cell population for creating dermal equivalents.
• The developed full-thickness skin model demonstrates improved accuracy and organization compared to previous in vitro models.
• This study validates the use of iPSC-derived populations for developing consistent, customized human skin equivalents.